Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 541299 | NSE Symbol : | ISIN : INE871Z01013 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
25-Apr-2025	01-May-2025	Accounts	Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/05/2025 inter alia to consider and approve the Audited Financial Statements of the Company for the Financial Year ending on March 2025
21-Feb-2025	21-Feb-2025	Change in Other Executives	Appointment of Ms. Saniya Hussain as Company Secretary of the Company wef 21.02.2025
08-Oct-2024	14-Oct-2024	Half Yearly Results	Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2024 inter alia to consider and approve unaudited financial statements for the half year ended September 30 2024 Unaudited Financial Results for the half year ended on September 30, 2024 (As per BSE Announcement Dated on 14/10/2024)
07-Sep-2024	07-Sep-2024	AGM	Outcome of Board Meeting
18-May-2024	30-May-2024	Accounts	Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve Approval of Financial statement for the year ended March 31 2024 Audited standalone Financial results of the Company for the Financial year ended March 2024 (As Per BSE Announcement Dated on 30.05.2024)
02-May-2024	02-May-2024	Change in Other Executives	Appointment of Ms. Namita Anand as Company Secretary and Compliance officer of the Company
01-Dec-2023	01-Dec-2023	Change in Other Executives	Appointment of Mr. Karan Kumar as Company Secretary and Compliance Officer of the Company w.e.f. 01.12.2023
07-Nov-2023	14-Nov-2023	Quarterly Results	Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve the un-audited Standalone Financial Results of the Company for the half year ended on September 30 2023 Unaudited financial results of the Company for the half year ended September 30, 2023 unaudited financial results for September 2023 (As Per BSE Announcement dated on 14.11.2023)
08-Sep-2023	08-Sep-2023	AGM	Outcome of Board Meeting held on September 08, 2023 Appointment of Secretarial Auditor (As per BSE Announcement Dated on 08/09/2023)
25-Aug-2023	25-Aug-2023	Change in Other Executives	Appointment of Company Secretary and Compliance Officer
23-May-2023	19-Jun-2023	Accounts	Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Board Meeting Intimation for The Board Meeting As Per Regulation 29 Of SEBI(Listing Obligations And Disclosure Requirement) Regulations 2015. Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/06/2023 ,inter alia, to consider and approve Intimation regarding postponement of Board Meeting. (As per BSE Announcement Dated on 30/05/2023) The Board Meeting to be held on 16/06/2023 has been revised to 19/06/2023 The Board Meeting to be held on 16/06/2023 has been revised to 19/06/2023 (As per BSE Announcement Dated on 12/06/2023) OUTCOME OF BOARD MEETING HELD ON 19.06.2023 (As per BSE Announcement Dated on 19/06/2023)
10-Nov-2022	14-Nov-2022	Half Yearly Results	Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we hereby inform that meeting of Board of Directors has been scheduled to be held on Monday November 14 2022 to inter alia consider and decide the following business matters: 1. To consider and approve Unaudited Financial Results of the Company for the half year ended September 30 2022 along with the Limited Review Report. 2. Any other Business matter with the permission of the Chair. We are hereby submitting the Unaudited Financial Results along with Limited Review Report for the half year ended on 30th September, 2022. 1. Un-audited Financial Results for the half year ended on 30th September, 2022. 2. Un-audited Statement of Assets and Liabilities for the half year ended on 30th September, 2022. 3. Cash Flow Statement for the half year ended on 30th September, 2022. 4. Limited Review Report for the half year ended 30th September, 2022. (As Per BSE Announcement Dated on 14/11/2022)
06-Sep-2022	06-Sep-2022	AGM	Outcome of Board Meeting held on 06th September 2022, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
23-May-2022	30-May-2022	Accounts	Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve Pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we hereby inform you that a meeting of the Board of Directors has been scheduled to be held on Monday May 30 2022 at 5.00 pm to inter alia consider and decide the following business matters: 1. To consider and approve Audited Financial Results of the Company for the year ended March 31 2022. 2. Any other Business matter with the permission of the Chair. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company at their meeting held on Monday, the 30th day of May 2022, has approved, inter-alia, the following Approval of Standalone Audited Financial Results For The Half Yearly and Year Ended 31st March, 2022 (As Per BSE Announcement Dated on 30/05/2022)
09-Mar-2022	09-Mar-2022	Change in Directors	Outcome of the Board Meeting as held on March 09, 2022. Dr Lalchandani Labs Limited would like to inform that Ms. Swati Chandra (DIN No.: 0009514968) has been appointed as a Additional Director (Non-Executive Director) of the Company with effect from 09th March, 2022. Intimation is hereby given that DR LALCHANDANI LABS LIMITED has appointed M/s Vikas Bagga & Co. as an Internal Auditor.

1 2

LOGIN HERE

Dr Lalchandani Labs Ltd

Board Meeting